Reversible myocardial dysfunction in a young woman with metastatic renal cell carcinoma treated with sunitinib.
Szmit
Sebastian
S
Department of Oncology, Military Institute of Health, Warsaw, Poland. s.szmit@gmail.com
Nurzyński
Pawel
P
Szaluś
Norbert
N
Opolski
Grzegorz
G
Szczylik
Cezary
C
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001794:Blood Pressure; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000556:secondary; D004232:Diuretics / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D015637:Gated Blood-Pool Imaging; D006333:Heart Failure / Q000139:chemically induced* / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D007211:Indoles / Q000009:adverse effects* / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008207:Lymphatic Metastasis; D008790:Metoprolol / Q000627:therapeutic use; D011758:Pyrroles / Q000009:adverse effects* / Q000627:therapeutic use; D000077210:Sunitinib; D016896:Treatment Outcome; D014336:Troponin / Q000097:blood
D000319:Adrenergic beta-Antagonists; D000970:Antineoplastic Agents; D004232:Diuretics; D007211:Indoles; D011758:Pyrroles; D014336:Troponin; D005665:Furosemide; D008790:Metoprolol; D000077210:Sunitinib